Wells Fargo’s Atara Biotherapeutics ATRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.34K | Hold |
951
| – | – | ﹤0.01% | 5561 |
|
|
2025
Q1 | $5.65K | Hold |
951
| – | – | ﹤0.01% | 5536 |
|
|
2024
Q4 | $12.7K | Sell |
951
-300
| -24% | -$3.99K | ﹤0.01% | 5386 |
|
|
2024
Q3 | $10.2K | Buy |
1,251
+936
| +297% | +$7.61K | ﹤0.01% | 5389 |
|
|
2024
Q2 | $2.68K | Sell |
315
-39,673
| -99% | -$337K | ﹤0.01% | 5592 |
|
|
2024
Q1 | $27.8K | Buy |
39,988
+4,623
| +13% | +$3.21K | ﹤0.01% | 5091 |
|
|
2023
Q4 | $18.1K | Sell |
35,365
-878
| -2% | -$450 | ﹤0.01% | 5235 |
|
|
2023
Q3 | $53.6K | Sell |
36,243
-13,290
| -27% | -$19.7K | ﹤0.01% | 4799 |
|
|
2023
Q2 | $79.7K | Sell |
49,533
-74,102
| -60% | -$119K | ﹤0.01% | 4902 |
|
|
2023
Q1 | $359K | Buy |
123,635
+110,885
| +870% | +$322K | ﹤0.01% | 3817 |
|
|
2022
Q4 | $41.8K | Sell |
12,750
-5,791
| -31% | -$19K | ﹤0.01% | 4645 |
|
|
2022
Q3 | $70K | Sell |
18,541
-12,955
| -41% | -$48.9K | ﹤0.01% | 4495 |
|
|
2022
Q2 | $246K | Buy |
31,496
+8,786
| +39% | +$68.6K | ﹤0.01% | 3928 |
|
|
2022
Q1 | $211K | Sell |
22,710
-30,456
| -57% | -$283K | ﹤0.01% | 4649 |
|
|
2021
Q4 | $837K | Sell |
53,166
-3,367
| -6% | -$53K | ﹤0.01% | 3997 |
|
|
2021
Q3 | $1.01M | Sell |
56,533
-100,411
| -64% | -$1.8M | ﹤0.01% | 3997 |
|
|
2021
Q2 | $2.44M | Sell |
156,944
-20,864
| -12% | -$325K | ﹤0.01% | 3344 |
|
|
2021
Q1 | $2.55M | Sell |
177,808
-20,434
| -10% | -$293K | ﹤0.01% | 3289 |
|
|
2020
Q4 | $3.89M | Buy |
198,242
+20,850
| +12% | +$409K | ﹤0.01% | 2942 |
|
|
2020
Q3 | $2.3M | Sell |
177,392
-757
| -0.4% | -$9.81K | ﹤0.01% | 3153 |
|
|
2020
Q2 | $2.6M | Buy |
178,149
+123,837
| +228% | +$1.8M | ﹤0.01% | 3026 |
|
|
2020
Q1 | $462K | Sell |
54,312
-48,392
| -47% | -$412K | ﹤0.01% | 3976 |
|
|
2019
Q4 | $1.69M | Sell |
102,704
-5,996
| -6% | -$98.8K | ﹤0.01% | 3440 |
|
|
2019
Q3 | $1.53M | Buy |
108,700
+6,671
| +7% | +$94.1K | ﹤0.01% | 3493 |
|
|
2019
Q2 | $2.05M | Buy |
102,029
+6,509
| +7% | +$131K | ﹤0.01% | 3307 |
|
|
2019
Q1 | $3.8M | Buy |
95,520
+2,711
| +3% | +$108K | ﹤0.01% | 2792 |
|
|
2018
Q4 | $3.22M | Buy |
92,809
+2,533
| +3% | +$88K | ﹤0.01% | 2826 |
|
|
2018
Q3 | $3.73M | Sell |
90,276
-296,396
| -77% | -$12.3M | ﹤0.01% | 2870 |
|
|
2018
Q2 | $14.2M | Buy |
386,672
+332,450
| +613% | +$12.2M | ﹤0.01% | 1766 |
|
|
2018
Q1 | $2.12M | Buy |
54,222
+8,616
| +19% | +$336K | ﹤0.01% | 3298 |
|
|
2017
Q4 | $825K | Sell |
45,606
-9,545
| -17% | -$173K | ﹤0.01% | 3973 |
|
|
2017
Q3 | $912K | Sell |
55,151
-1,713
| -3% | -$28.3K | ﹤0.01% | 3850 |
|
|
2017
Q2 | $796K | Sell |
56,864
-1,388
| -2% | -$19.4K | ﹤0.01% | 3821 |
|
|
2017
Q1 | $1.2M | Buy |
58,252
+4,791
| +9% | +$98.4K | ﹤0.01% | 3556 |
|
|
2016
Q4 | $759K | Buy |
53,461
+17,754
| +50% | +$252K | ﹤0.01% | 3825 |
|
|
2016
Q3 | $764K | Sell |
35,707
-1,135
| -3% | -$24.3K | ﹤0.01% | 3599 |
|
|
2016
Q2 | $830K | Buy |
36,842
+4,808
| +15% | +$108K | ﹤0.01% | 3538 |
|
|
2016
Q1 | $610K | Buy |
32,034
+533
| +2% | +$10.2K | ﹤0.01% | 3666 |
|
|
2015
Q4 | $832K | Buy |
31,501
+9,784
| +45% | +$258K | ﹤0.01% | 3518 |
|
|
2015
Q3 | $682K | Buy |
21,717
+18,747
| +631% | +$589K | ﹤0.01% | 3654 |
|
|
2015
Q2 | $157K | Buy |
2,970
+1,955
| +193% | +$103K | ﹤0.01% | 4600 |
|
|
2015
Q1 | $42K | Buy |
1,015
+415
| +69% | +$17.2K | ﹤0.01% | 4898 |
|
|
2014
Q4 | $16K | Buy |
+600
| New | +$16K | ﹤0.01% | 5230 |
|